Kirn David

CIK 00018340211 companyEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001834021

Recent Transactions

31 trades

Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2025-03-06+267,500→ 267,500 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-07-10$22.49/sh−12,923→ 1,059,153 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-07-10−1,270→ 148,730 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-07-10$15.78/sh+1,270→ 1,072,076 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-07-10−11,653→ 565,417 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-07-10$14.42/sh+11,653→ 1,070,806 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-06-24−12,930→ 577,070 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-06-24$23.10/sh−12,930→ 1,059,153 total
Exercise/Conversion
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-06-24$14.42/sh+12,930→ 1,072,083 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-02-08$27.13/sh−92,001→ 1,059,153 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-01-23$18.41/sh−5,696→ 1,151,154 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-01-05$19.56/sh−28,104→ 1,156,983 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-01-05$20.11/sh−133→ 1,156,850 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2024-01-04$20.31/sh−40,732→ 1,185,087 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-12-18$18.13/sh−4,702→ 1,225,819 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-12-15$17.27/sh−28,632→ 1,230,521 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-12-11+590,000→ 590,000 total
Gift
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-05-02−600,000→ 1,259,153 total
Gift
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-05-02+600,000→ 600,000 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-02-22$20.22/sh−16,449→ 1,859,153 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-02-21$20.93/sh−17,090→ 1,876,509 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-02-21$21.49/sh−907→ 1,875,602 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-02-10+222,000→ 222,000 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-01-20$20.19/sh−8,625→ 1,893,599 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2023-01-19$20.03/sh−10,899→ 1,902,224 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2022-12-16$22.66/sh−27,595→ 1,939,472 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2022-12-16$23.39/sh−26,349→ 1,913,123 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2022-12-15$24.13/sh−1,500→ 1,967,067 total
Sale
4D Molecular Therapeutics, Inc.$FDMT
Common Stock
2022-12-15$23.56/sh−31,433→ 1,968,567 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-02-01+150,000→ 150,000 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-03-08+150,000→ 150,000 total

Companies

4D Molecular Therapeutics, Inc.
Director, Chief Executive Officer
$FDMT

Recent Filings

Address

C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608

View on SEC.gov